Request Sample Inquiry
Psychedelic Drugs Market

Psychedelic Drugs Market

Psychedelic Drugs Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

197

Base Year:

2023

Date

Feb - 2024

Format:

PDF XLS PPT

Report Code:

VMR-2432

Segments Covered
  • By Source By Source Synthetic, Natural
  • By Therapeutic Drugs By Therapeutic Drugs Psilocybin, LSD, MDMA, DMT, Ketamine
  • By Route of Administration By Route of Administration Oral, Injectable, Inhalation
  • By Indication By Indication Alzheimer Dementia, Anorexia and Obesity, Anxiety & Depressive Disorders, Cluster Headaches, Obsessive Compulsive Disorders, Personality Disorder, Post-Traumatic Stress Disorder, Substance Abuse Disorders, Terminal Cancer Distress
  • By Distribution Channel By Distribution Channel Hospital Pharmacies (Dominating 57.3%), Retail Pharmacies, Online Pharmacies
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 2.91 Billion
Revenue 2032Revenue 2032: USD 8.85 Billion
Revenue CAGRRevenue CAGR (2024 - 2032): 13.2%
Fastest Growing Region Fastest Growing Region (2024 - 2032) Asia Pacific
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Psychedelic Drugs Market - Segment Analysis
    1. Overview
    2. Global Psychedelic Drugs Market, 2016 - 2028 (USD Million)
    3. Global Psychedelic Drugs Market - by Source
      1. By Synthetic
      2. By Natural
    4. Global Psychedelic Drugs Market - by Therapeutic Drugs
      1. By Psilocybin
      2. By LSD
      3. By MDMA
      4. By DMT
      5. By Ketamine
    5. Global Psychedelic Drugs Market - by Route of Administration
      1. By Oral
      2. By Injectable
      3. By Inhalation
    6. Global Psychedelic Drugs Market - by Indication
      1. By Alzheimer Dementia
      2. By Anorexia and Obesity
      3. By Anxiety & Depressive Disorders
      4. By Cluster Headaches
      5. By Obsessive Compulsive Disorders
      6. By Personality Disorder
      7. By Post-Traumatic Stress Disorder
      8. By Substance Abuse Disorders
      9. By Terminal Cancer Distress
    7. Global Psychedelic Drugs Market - by Distribution Channel
      1. By Hospital Pharmacies (Dominating 57.3%)
      2. By Retail Pharmacies
      3. By Online Pharmacies
    8. Global Psychedelic Drugs Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    9. Market comparative analysis
  4. North America Psychedelic Drugs Market - Segment Analysis
    1. Overview
    2. North America Psychedelic Drugs Market, 2016 - 2028 (USD Million)
    3. North America Psychedelic Drugs Market, by Source
      1. By Synthetic
      2. By Natural
    4. North America Psychedelic Drugs Market, by Therapeutic Drugs
      1. By Psilocybin
      2. By LSD
      3. By MDMA
      4. By DMT
      5. By Ketamine
    5. North America Psychedelic Drugs Market, by Route of Administration
      1. By Oral
      2. By Injectable
      3. By Inhalation
    6. North America Psychedelic Drugs Market, by Indication
      1. By Alzheimer Dementia
      2. By Anorexia and Obesity
      3. By Anxiety & Depressive Disorders
      4. By Cluster Headaches
      5. By Obsessive Compulsive Disorders
      6. By Personality Disorder
      7. By Post-Traumatic Stress Disorder
      8. By Substance Abuse Disorders
      9. By Terminal Cancer Distress
    7. North America Psychedelic Drugs Market, by Distribution Channel
      1. By Hospital Pharmacies (Dominating 57.3%)
      2. By Retail Pharmacies
      3. By Online Pharmacies
    8. North America Psychedelic Drugs Market, by Country
      1. U.S.
        1. U.S. Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. U.S. Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. U.S. Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. U.S. Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. U.S. Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
      2. Canada
        1. Canada Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. Canada Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. Canada Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. Canada Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. Canada Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
      3. Mexico
        1. Mexico Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. Mexico Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. Mexico Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. Mexico Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. Mexico Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
  5. Europe Psychedelic Drugs Market - Segment Analysis
    1. Overview
    2. Europe Psychedelic Drugs Market, 2016 - 2028 (USD Million)
    3. Europe Psychedelic Drugs Market, by Source
      1. By Synthetic
      2. By Natural
    4. Europe Psychedelic Drugs Market, by Therapeutic Drugs
      1. By Psilocybin
      2. By LSD
      3. By MDMA
      4. By DMT
      5. By Ketamine
    5. Europe Psychedelic Drugs Market, by Route of Administration
      1. By Oral
      2. By Injectable
      3. By Inhalation
    6. Europe Psychedelic Drugs Market, by Indication
      1. By Alzheimer Dementia
      2. By Anorexia and Obesity
      3. By Anxiety & Depressive Disorders
      4. By Cluster Headaches
      5. By Obsessive Compulsive Disorders
      6. By Personality Disorder
      7. By Post-Traumatic Stress Disorder
      8. By Substance Abuse Disorders
      9. By Terminal Cancer Distress
    7. Europe Psychedelic Drugs Market, by Distribution Channel
      1. By Hospital Pharmacies (Dominating 57.3%)
      2. By Retail Pharmacies
      3. By Online Pharmacies
    8. Europe Psychedelic Drugs Market, by Country
      1. Germany
        1. Germany Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. Germany Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. Germany Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. Germany Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. Germany Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
      2. UK
        1. UK Market, By Source
          1. By Synthetic
          2. By Natural
        2. UK Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. UK Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. UK Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. UK Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
      3. France
        1. France Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. France Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. France Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. France Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. France Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
      4. Spain
        1. Spain Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. Spain Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. Spain Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. Spain Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. Spain Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
      5. Italy
        1. Italy Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. Italy Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. Italy Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. Italy Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. Italy Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
      6. BENELUX
        1. BENELUX Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. BENELUX Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. BENELUX Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. BENELUX Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. BENELUX Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
      7. Rest of Europe
        1. Rest Of Europe Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. Rest Of Europe Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. Rest Of Europe Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. Rest Of Europe Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. Rest Of Europe Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
  6. Asia Pacific Psychedelic Drugs Market - Segment Analysis
    1. Overview
    2. Asia Pacific Psychedelic Drugs Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Psychedelic Drugs Market, by Source
      1. By Synthetic
      2. By Natural
    4. Asia Pacific Psychedelic Drugs Market, by Therapeutic Drugs
      1. By Psilocybin
      2. By LSD
      3. By MDMA
      4. By DMT
      5. By Ketamine
    5. Asia Pacific Psychedelic Drugs Market, by Route of Administration
      1. By Oral
      2. By Injectable
      3. By Inhalation
    6. Asia Pacific Psychedelic Drugs Market, by Indication
      1. By Alzheimer Dementia
      2. By Anorexia and Obesity
      3. By Anxiety & Depressive Disorders
      4. By Cluster Headaches
      5. By Obsessive Compulsive Disorders
      6. By Personality Disorder
      7. By Post-Traumatic Stress Disorder
      8. By Substance Abuse Disorders
      9. By Terminal Cancer Distress
    7. Asia Pacific Psychedelic Drugs Market, by Distribution Channel
      1. By Hospital Pharmacies (Dominating 57.3%)
      2. By Retail Pharmacies
      3. By Online Pharmacies
    8. Asia Pacific Psychedelic Drugs Market, by Country
      1. China
        1. China Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. China Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. China Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. China Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. China Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
      2. Japan
        1. Japan Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. Japan Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. Japan Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. Japan Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. Japan Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
      3. India
        1. India Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. India Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. India Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. India Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. India Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
      4. South Korea
        1. South Korea Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. South Korea Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. South Korea Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. South Korea Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. South Korea Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
      5. South East Asia
        1. South East Asia Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. South East Asia Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. South East Asia Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. South East Asia Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. South East Asia Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. Rest of Asia Pacific Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. Rest of Asia Pacific Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. Rest of Asia Pacific Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. Rest of Asia Pacific Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
  7. Latin America Psychedelic Drugs Market - Segment Analysis
    1. Overview
    2. Latin America Psychedelic Drugs Market, 2016 - 2028 (USD Million)
    3. Latin America Psychedelic Drugs Market, by Source
      1. By Synthetic
      2. By Natural
    4. Latin America Psychedelic Drugs Market, by Therapeutic Drugs
      1. By Psilocybin
      2. By LSD
      3. By MDMA
      4. By DMT
      5. By Ketamine
    5. Latin America Psychedelic Drugs Market, by Route of Administration
      1. By Oral
      2. By Injectable
      3. By Inhalation
    6. Latin America Psychedelic Drugs Market, by Indication
      1. By Alzheimer Dementia
      2. By Anorexia and Obesity
      3. By Anxiety & Depressive Disorders
      4. By Cluster Headaches
      5. By Obsessive Compulsive Disorders
      6. By Personality Disorder
      7. By Post-Traumatic Stress Disorder
      8. By Substance Abuse Disorders
      9. By Terminal Cancer Distress
    7. Latin America Psychedelic Drugs Market, by Distribution Channel
      1. By Hospital Pharmacies (Dominating 57.3%)
      2. By Retail Pharmacies
      3. By Online Pharmacies
    8. Latin America Psychedelic Drugs Market, by Country
      1. Brazil
        1. Brazil Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. Brazil Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. Brazil Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. Brazil Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. Brazil Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
      2. Argentina
        1. Argentina Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. Argentina Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. Argentina Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. Argentina Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. Argentina Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
      3. Rest of Latin America
        1. Rest of Latin America Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. Rest of Latin America Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. Rest of Latin America Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. Rest of Latin America Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. Rest of Latin America Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
  8. Middle East & Africa Psychedelic Drugs Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Psychedelic Drugs Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Psychedelic Drugs Market, by Source
      1. By Synthetic
      2. By Natural
    4. Middle East & Africa Psychedelic Drugs Market, by Therapeutic Drugs
      1. By Psilocybin
      2. By LSD
      3. By MDMA
      4. By DMT
      5. By Ketamine
    5. Middle East & Africa Psychedelic Drugs Market, by Route of Administration
      1. By Oral
      2. By Injectable
      3. By Inhalation
    6. Middle East & Africa Psychedelic Drugs Market, by Indication
      1. By Alzheimer Dementia
      2. By Anorexia and Obesity
      3. By Anxiety & Depressive Disorders
      4. By Cluster Headaches
      5. By Obsessive Compulsive Disorders
      6. By Personality Disorder
      7. By Post-Traumatic Stress Disorder
      8. By Substance Abuse Disorders
      9. By Terminal Cancer Distress
    7. Middle East & Africa Psychedelic Drugs Market, by Distribution Channel
      1. By Hospital Pharmacies (Dominating 57.3%)
      2. By Retail Pharmacies
      3. By Online Pharmacies
    8. Middle East & Africa Psychedelic Drugs Market, by Country
      1. GCC Countries
        1. GCC Countries Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. GCC Countries Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. GCC Countries Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. GCC Countries Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. GCC Countries Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
      2. South Africa
        1. South Africa Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. South Africa Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. South Africa Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. South Africa Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. South Africa Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Psychedelic Drugs Market, By Source
          1. By Synthetic
          2. By Natural
        2. Rest of Middle East & Africa Psychedelic Drugs Market, By Therapeutic Drugs
          1. By Psilocybin
          2. By LSD
          3. By MDMA
          4. By DMT
          5. By Ketamine
        3. Rest of Middle East & Africa Psychedelic Drugs Market, By Route of Administration
          1. By Oral
          2. By Injectable
          3. By Inhalation
        4. Rest of Middle East & Africa Psychedelic Drugs Market, By Indication
          1. By Alzheimer Dementia
          2. By Anorexia and Obesity
          3. By Anxiety & Depressive Disorders
          4. By Cluster Headaches
          5. By Obsessive Compulsive Disorders
          6. By Personality Disorder
          7. By Post-Traumatic Stress Disorder
          8. By Substance Abuse Disorders
          9. By Terminal Cancer Distress
        5. Rest of Middle East & Africa Psychedelic Drugs Market, By Distribution Channel
          1. By Hospital Pharmacies (Dominating 57.3%)
          2. By Retail Pharmacies
          3. By Online Pharmacies
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Atai Life Sciences NV
    2. Compass Pathways PLC
    3. MindMed Inc
    4. Takeda Pharmaceutical Company Limited
    5. Pfizer Inc.
    6. Alkermes
    7. Celon Pharma S.A
    8. Seelos Therapeutics Inc.
    9. HAVN Life Sciences Inc.
    10. Numinus Wellness Inc.
    11. Eli Lilly and Company
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
FAQ
Frequently Asked Question

  • The global Psychedelic Drugs valued at USD 2.91 Billion in 2023 and is expected to reach USD 8.85 Billion in 2032 growing at a CAGR of 13.2%.

  • The prominent players in the market are Atai Life Sciences NV, Compass Pathways PLC, MindMed Inc, Takeda Pharmaceutical Company Limited, Pfizer Inc., Alkermes, Celon Pharma S.A, Seelos Therapeutics Inc., HAVN Life Sciences Inc., Numinus Wellness Inc., Eli Lilly and Company.

  • The market is project to grow at a CAGR of 13.2% between 2024 and 2032.

  • The driving factors of the Psychedelic Drugs include

  • North America was the leading regional segment of the Psychedelic Drugs in 2023.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy